
Kancera AB (publ) (KAN.ST)
KAN.ST Stock Price Chart
Explore Kancera AB (publ) interactive price chart. Choose custom timeframes to analyze KAN.ST price movements and trends.
KAN.ST Company Profile
Discover essential business fundamentals and corporate details for Kancera AB (publ) (KAN.ST) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
25 Feb 2011
Employees
5.00
Website
https://www.kancera.comCEO
Peter Selin
Description
Kancera AB (Publ) develops drugs for inflammatory diseases and cancer in Sweden and internationally. The company is developing small molecule drug candidates KAND567, which is in phase IIa clinical trial for inflammatory heart disease following infarction, as well as KAND145, which is in phase I study in healthy subjects to document desired dose levels against cancer; and Phase IIa study for the treatment of ovarian cancer. It also develops HDAC for the treatment of nerve inflammation and pain; and ROR1 inhibitors for the treatment of solid tumors and blood cancers. Kancera AB (Publ) was founded in 2010 and is based in Solna, Sweden.
KAN.ST Financial Timeline
Browse a chronological timeline of Kancera AB (publ) corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 21 May 2026
Upcoming earnings on 19 Feb 2026
Upcoming earnings on 21 Nov 2025
Earnings released on 22 Aug 2025
Earnings released on 23 May 2025
EPS came in at -kr 0.11 .
Earnings released on 21 Feb 2025
EPS came in at -kr 0.08 , while revenue for the quarter reached kr 14.00K .
Earnings released on 15 Nov 2024
EPS came in at -kr 0.09 falling short of the estimated kr 0.46 by -119.60%.
Earnings released on 23 Aug 2024
EPS came in at -kr 0.09 surpassing the estimated -kr 0.17 by +47.06%.
Earnings released on 17 May 2024
EPS came in at -kr 0.13 surpassing the estimated -kr 0.20 by +35.00%.
Stock split effective on 29 Feb 2024
Shares were split 1023 : 1000 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 23 Feb 2024
EPS came in at -kr 0.22 falling short of the estimated -kr 0.15 by -51.06%, while revenue for the quarter reached kr 443.00K .
Earnings released on 17 Nov 2023
EPS came in at -kr 0.13 surpassing the estimated -kr 0.21 by +40.15%.
Earnings released on 18 Aug 2023
EPS came in at -kr 0.22 falling short of the estimated -kr 0.16 by -41.47%, while revenue for the quarter reached kr 456.00K .
Earnings released on 19 May 2023
EPS came in at -kr 0.21 falling short of the estimated -kr 0.13 by -69.25%, while revenue for the quarter reached kr 136.00K .
Earnings released on 21 Feb 2023
EPS came in at -kr 0.21 , while revenue for the quarter reached kr 27.00K .
Stock split effective on 27 Oct 2022
Shares were split 146 : 125 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 26 Oct 2022
EPS came in at -kr 0.17 , while revenue for the quarter reached kr 220.00K .
Earnings released on 19 Aug 2022
EPS came in at -kr 0.24 , while revenue for the quarter reached kr 227.00K .
Earnings released on 20 May 2022
EPS came in at -kr 0.21 , while revenue for the quarter reached kr 279.00K .
Earnings released on 18 Feb 2022
EPS came in at -kr 0.23 , while revenue for the quarter reached kr 1.14M .
Earnings released on 19 Nov 2021
EPS came in at -kr 0.31 .
Earnings released on 30 Sept 2021
EPS came in at -kr 0.17 , while revenue for the quarter reached kr 416.00K .
Stock split effective on 28 Apr 2021
Shares were split 253 : 250 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 31 Mar 2021
EPS came in at -kr 0.25 , while revenue for the quarter reached kr 565.00K .
Stock split effective on 24 Feb 2021
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 19 Feb 2021
EPS came in at -kr 0.27 , while revenue for the quarter reached -kr 4.67M .
Earnings released on 20 Nov 2020
EPS came in at -kr 0.18 , while revenue for the quarter reached kr 49.00K .
KAN.ST Stock Performance
Access detailed KAN.ST performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.